The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.
The DCP Community Oncology and Prevention Trials Research Group administers this program.
About NCORP
The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.
Grantee Details
No matching Grants were found.
Clinical Trials
Title Sort descending | Intervention | Sponsor | Status |
---|---|---|---|
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer | Wake Forest University Health Sciences | Recruiting | |
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer | Naloxegol, Placebo, Laboratory Biomarker Analysis, Quality-of-Life Assessment | Alliance for Clinical Trials in Oncology | Active, not recruiting |
National Cancer Institute "Cancer Moonshot Biobank" | Biospecimen Collection, Medical Chart Review | National Cancer Institute (NCI) | Recruiting |
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery | cognitive assessment, laboratory biomarker analysis, magnetic resonance imaging, quality-of-life assessment, questionnaire administration | Radiation Therapy Oncology Group | Completed |
NCI COVID-19 in Cancer Patients, NCCAPS Study | Biospecimen Collection, Data Collection, Quality-of-Life Assessment, Questionnaire Administration | National Cancer Institute (NCI) | Active, not recruiting |
Neuropsychological and Behavioral Testing in Younger Patients With Cancer | Cognitive Assessment, Quality-of-Life Assessment | Children's Oncology Group | Active, not recruiting |
Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery | Laboratory Biomarker Analysis, Nutritional Intervention, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration | SWOG Cancer Research Network | Active, not recruiting |
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients | Megestrol Acetate, Olanzapine, Questionnaire Administration | Alliance for Clinical Trials in Oncology | Recruiting |
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy | Dexamethasone, Fosaprepitant Dimeglumine, Olanzapine, Ondansetron Hydrochloride, Palonosetron Hydrochloride, Placebo | Alliance for Clinical Trials in Oncology | Completed |
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors | Laboratory Biomarker Analysis, Omega-3 Fatty Acid, Placebo, Questionnaire Administration | Gary Morrow | Completed |